A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Clinical trial NCT06221475 · COMPLETED

Trial details

NCT number: NCT06221475
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer EGFR Mutation HER2 Mutation Healthy Volunteers

Start date: 2024-01-25
Primary completion: 2024-04-05
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.